Ispire Technology Inc. Files 8-K
Ticker: ISPR · Form: 8-K · Filed: Nov 18, 2024 · CIK: 1948455
| Field | Detail |
|---|---|
| Company | Ispire Technology INC. (ISPR) |
| Form Type | 8-K |
| Filed Date | Nov 18, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 8-k
Related Tickers: ISP
TL;DR
ISP stock filing 8-K, no specifics yet.
AI Summary
Ispire Technology Inc. filed an 8-K on November 18, 2024, reporting other events and financial statements. The filing does not contain specific details about the nature of these events or financial figures within the provided text.
Why It Matters
This filing indicates that Ispire Technology Inc. has made a regulatory submission to the SEC, which may contain important updates for investors.
Risk Assessment
Risk Level: low — The filing is a standard procedural document without immediate disclosed financial or operational impacts.
Key Players & Entities
- Ispire Technology Inc. (company) — Registrant
- November 18, 2024 (date) — Date of Report
- 001-41680 (other) — SEC File Number
- 19700 Magellan Drive Los Angeles , CA 90502 (address) — Principal Executive Offices
FAQ
What specific events are being reported in this 8-K filing?
The provided text of the 8-K filing indicates 'Other Events' and 'Financial Statements and Exhibits' as item information, but does not detail the specific nature of these events or the content of the financial statements.
When was this 8-K filing submitted by Ispire Technology Inc.?
The filing was submitted on November 18, 2024.
What is the SEC file number for Ispire Technology Inc.?
The SEC file number for Ispire Technology Inc. is 001-41680.
Where are Ispire Technology Inc.'s principal executive offices located?
Ispire Technology Inc.'s principal executive offices are located at 19700 Magellan Drive, Los Angeles, CA 90502.
Does the filing mention any former company names or addresses?
The filing states 'Not Applicable' for Former Name or Former Address, if Changed Since Last Report.
Filing Stats: 458 words · 2 min read · ~2 pages · Grade level 10.8 · Accepted 2024-11-18 08:35:27
Key Financial Figures
- $0.0001 — ch registered Common Stock, par value $0.0001 per share ISPR The Nasdaq Stock Mar
Filing Documents
- ea0221581-8k_ispire.htm (8-K) — 26KB
- ea022158101ex99-1_ispire.htm (EX-99.1) — 15KB
- 0001213900-24-099371.txt ( ) — 215KB
- ispr-20241118.xsd (EX-101.SCH) — 3KB
- ispr-20241118_lab.xml (EX-101.LAB) — 33KB
- ispr-20241118_pre.xml (EX-101.PRE) — 22KB
- ea0221581-8k_ispire_htm.xml (XML) — 4KB
01 Other Events
Item 8.01 Other Events. On November 18, 2024, Ispire Technology Inc. (the "Company") issued a press release announcing a positive in person pre-PMTA submission meeting with the U.S. Food and Drug Administration. A copy of the press release issued by the Company is attached hereto as Exhibit 99.1 and is incorporated by reference into this Item 8.01.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits The following exhibits are being filed with this Current Report on Form 8-K: Exhibit No. Description 99.1 Press Release of Ispire Technology Inc. issued on November 18, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 1 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Ispire Technology Inc. By: /s/ Michael Wang Name: Michael Wang Title: Co-Chief Executive Officer Dated: November 18, 2024 2